Obesity and osteoporosis

Annales d'Endocrinologie

Volumn 67, Issue 2, 2006, Pages 125-129

  Reid, I R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; AMYLIN; ANTIDIABETIC AGENT; HORMONE; INSULIN; LEPTIN; RESISTIN;

ADIPOCYTE; BODY FAT; BODY WEIGHT; BONE DENSITY; HUMAN; NUTRITION; OBESITY; OSTEOPOROSIS; PATHOGENESIS; PREMENOPAUSE; REVIEW; RISK FACTOR; X RAY ANALYSIS;

EID: 33646426143     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(06)72567-7     Document Type: Article

References (76)

1. Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H. Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabetic Medicine 2000 ; 17 : 124-9.
2. Alam AS, Moonga BS, Bevis PJ, Huang CL, Zaidi M. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp Physiol 1993 ; 78 : 183-96.
3. Alderman BW, Weiss NS, Daling JR, Ure CL, Ballard JH. Reproductive history and postmenopausal risk of hip and forearm fracture. Am J Epidemiol 1986 ; 124 : 262-7.
4. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001 ; 7 : 947-53.
5. Berner HS, Lyngstadaas SP, Spahr A et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004 ; 35 : 842-9.
6. Bollag RJ, Zhong Q, Ding KH et al. Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Molecular & Cellular Endocrinology 2001 ; 177 : 35-41.
7. Buchanan CM, Phillips ARJ, Cooper GJS. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochemical Journal 2001 ; 360 : 431-9.
8. Cornish J, Callon KE, Cooper GJS, Reid IR. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun 1995 ; 207 : 133-9.
9. Cornish J, Callon KE, Reid IR. Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int 1996 ; 59 : 492-5.
10. Cornish J, Callon KE, King AR, Cooper GJS, Reid IR. Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Amer J Physiol-Endocrinol Metab 1998 ; 38 : E694-E699.
11. Cornish J, Callon KE, Bava U et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2002 ; 175 : 405-15.
12. Cornish J, Callon KE, Mountjoy KG et al. α-Melanocyte stimulating hormone (α-MSH) is a novel regulator of bone. Amer J Physiol 2003 ; 284 : E1181-E1190.
13. Dagogojack S, Alali N, Qurttom M. Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab 1997 ; 82 : 2821-5.
14. Ensrud KE, Lipschutz RC, Cauley JA et al. Body size and hip fracture risk in older women - a prospective study. Am J Med 1997 ; 103 : 274-80.
15. Farmer ME, Harris T, Madans JH, Wallace RB, Coroni-Huntley J, White LR. Anthropometric indicators and hip fracture. The NHANES I epidemiologic follow-up study. J Am Geriatr Soc 1989 ; 37 : 9-16.
16. Farooqi IS, Jebb SA, Langmack G et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency [see comments]. N Engl J Med 1999 ; 341 : 879-84.
17. Felson DT, Zhang YQ, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women - the Framingham study. J Bone Miner Res 1993 ; 8 : 567-73.
18. Fukushima N, Hanada R, Teranishi H et al. Ghrelin directly regulates bone formation. J Bone Mineral Res 2005 ; 20 : 790-8.
19. Goulding A, Taylor RW. Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 1998 ; 63 : 456-8.
20. Gregoriou O, Kouskouni E, Bakas P et al. Bone mineral density in women with idiopathic hirsutism. Gynecological Endocrinology 2000 ; 14 : 364-8.
21. Grinspoon SK, Baum HBA, Kim V, Coggins C, Klibanski A. Decreased bone formation and increased mineral dissolution during acute fasting young women. J Clin Endocrinol Metab 1995 ; 80 : 3628-33.
22. Haderslev KV, Jeppesen PB, Hartmann B et al. Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scandinavian Journal of Gastroenterology 2002 ; 37 : 392-8.
23. Haffner SM, Bauer RL. The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. Metabolism 1993 ; 42 : 735-8.
24. Hassager C, Christiansen C. Influence of soft tissue body composition on bone mass and metabolism. Bone 1989 ; 10 : 415-9.
25. Heaney RP, Bargerlux MJ, Davies KM, Ryan RA, Johnson ML, Gong G. Bone dimensional change with age - interactions of genetic, hormonal, and body size variables. Osteoporos Int 1997 ; 7 : 426-31.
26. Hickman J, McElduff A. Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106-01: an osteoblast-like cell. Endocrinology 1989 ; 124 : 701-76.
27. Holloway WR, Collier FM, Aitken CJ et al. Leptin inhibits osteoclast generation. J Bone Miner Res 2002 ; 17 : 200-9.
28. Hutchinson TA, Polansky SM, Feinstein AR. Post-menopausal oestrogens protect against fractures of hip and distal radius. Lancet 1979 ; ii : 705-9.
29. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity - changes related to severe overweight and dietary weight reduction. Acta Endocrinol 1993 ; 129 : 393-8.
30. Jang M, Mistry A, Swick AG, Romsos DR. Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice. J Nutr 2000 ; 130 : 2813-20.
31. Johnell O, Oneill T, Felsenberg D et al. Anthropometric measurements and vertebral deformities. Am J Epidemiol 1997 ; 146 : 287-93.
32. Khosla S, Atkinson EJ, Riggs BL, Melton LJ. Relationship between body composition and bone mass in women. J Bone Miner Res 1996 ; 11 : 857-63.
33. Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 1987 ; 317 : 1169-74.
34. Laharrague P, Larrouy D, Fontanilles AM et al. High expression of leptin by human bone marrow adipocytes in primary culture. Faseb J 1998 ; 12 : 747-52.
35. Lau EMC, Chan YH, Chan M et al. Vertebral deformity in Chinese men: Prevalence, risk factors, bone mineral density, and body composition measurements. Calcif Tissue Int 2000 ; 66 : 47-52.
36. Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Experimental & Clinical Endocrinology & Diabetes 2001 ; 109 : S493-S514.
37. Marcus R, Greendale G, Blunt BA et al. Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial. J Bone Miner Res 1994 ; 9 : 1467-76.
38. Mazess R, Barden H, Ettinger B et al. Spine and femur density using dual-photon absorptiometry in US white women. Bone Miner 1987 ; 2 : 211-9.
39. Mizuno A, Murakami T, Otani S, Kuwajima M, Shima K. Leptin affects pancreatic endocrine functions through the sympathetic nervous system. Endocrinology 1998 ; 139 : 3863-70.
40. Newberry D, Wickham C, Hodkinson HM. How does obesity protect against osteoporosis? J Clin Exp Gerontol 1990 ; 12 : 203-7.
41. Nguyen TV, Sambrook PN, Eisman JA. Bone loss, physical activity, and weight change in elderly women - the Dubbo osteoporosis epidemiology study. J Bone Miner Res 1998 ; 13 : 1458-67.
42. Oshima K, Nampei A, Matsuda M et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochemical and Biophysical Research Communications 2005 ; 331 : 520-6.
43. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000 ; 102 : 1296-301.
44. Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981 ; 95 : 28-31.
45. Pasco JA, Henry MJ, Kotowicz MA et al. Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 2001 ; 86 : 1884-7.
46. Pelleymounter MA, Cullen MJ, Baker MB et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995 ; 269 : 540-3.
47. Pluijm SMF, Visser M, Smit JH, Popp-Snijders C, Roos JC, Lips P. Determinants of bone mineral density in older men and women: body composition as mediator. J Bone Miner Res 2001 ; 16 : 2142-51.
48. Pun KK, Lau P, Ho PW. The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. J Bone Miner Res 1989 ; 4 : 853-62.
49. Ravn P, Cizza G, Bjarnason NH et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 1999 ; 14 : 1622-7.
50. Reid IR, Ames R, Evans MC et al. Determinants of total body and regional bone mineral density in normal postmenopausal women- a key role for fat mass. J Clin Endocrinol Metab 1992 ; 75 : 45-51.
51. Reid IR, Plank LD, Evans MC. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 1992 ; 75 : 779-82.
52. Reid IR, Evans MC, Cooper GJS, Ames RW, Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 1993 ; 265 : E655-E659.
53. Reid IR, Ames RW, Evans MC, Sharpe SJ, Gamble GD. Determinants of the rate of bone loss in normal postmenopausal women. J Clin Endocrinol Metab 1994 ; 79 : 950-4.
54. Reid IR, Evans MC, Ames RW. Volumetric bone density of the lumbar spine is related to fat mass but not lean mass in normal postmenopausal women. Osteoporos Int 1994 ; 4 : 362-7.
55. Reid IR. Relationships among body mass, its components, and bone. IBMS BoneKEy 2002 ; 10.1138/ibmske : 2002055.
56. Reseland JE, Syversen U, Bakke I et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001 ; 16 : 1426-33.
57. Revilla M, Villa LF, Sanchez-Atrio A, Hernandez ER, Rico H. Influence of body mass index on the age-related slope of total and regional bone mineral content. Calcif Tissue Int 1997 ; 61 : 134-8.
58. Ricci TA, Heymsfield SB, Pierson RN, Stahl T, Chowdhury HA, Shapses SA. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr 2001 ; 73 : 347-52.
59. Riis BJ, Rodbro P, Christiansen C. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcif Tissue Int 1986 ; 38 : 318-22.
60. Schott AM, Cormier C, Hans D et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: The EPIDOS prospective study. Osteoporos Int 1998 ; 8 : 247-54.
61. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke HZ, Swick AG, Leptin is a potent stimulator of bone growth in ob/ob mice. Regulatory Peptides 2000 ; 92 : 73-8.
62. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001 ; 409 : 307-12.
63. Stolk RP, Vandaele PLA, Pols HAP et al. Hyperinsulinemia and bone mineral density in an elderly population - the Rotterdam study. Bone 1996 ; 18 : 545-9.
64. Sufang C, Nemoto K, Kurose R, Kobayashi N, Kubo K, Itabashi A. Different expression of leptin receptor variants in MC3T3-E1 osteoblastic cells and ATDC-5 chondroblastic cells. J Bone Miner Res 2000 ; 15 (suppl 1) : S466.
65. Taaffe DR, Cauley JA, Danielson M et al. Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the Health, Aging, and Body Composition Study. J Bone Miner Res 2001 ; 16 : 1343-52.
66. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999 ; 140 : 1630-8.
67. Tremollieres FA, Pouilles JM, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women - a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 1993 ; 77 : 683-6.
68. Vesterby A, Mosekilde L, Gundersen HJ et al. Biologically meaningful determinants of the in vitro strength of lumbar vertebrae. Bone 1991 ; 12 : 219-24.
69. Wang CZ, Zhang Y, Xiong YL, Lee CJ. Bone composition and strength of female rats subjected to different rates of weight reduction. Nutrition Research 2000 ; 20 : 1613-22.
70. Wang Y, Lam KS, Xu JY et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005 ; 280 : 18341-7.
71. Wetvik J. Radiological features in generalized lipodystrophy. Acta Paediatrica 1996 ; 413 (suppl) : 44-51.
72. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001 ; 86 : 1930-5.
73. Williams AR, Weiss NS, Ure CL, Ballard J, Daling JR. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 1982 ; 60 : 695-9.
74. Yamauchi M, Sugimoto T, Yamaguchi T et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol 2001 ; 55 : 341-7.
75. Young D, Hopper JL, Macinnis RJ, Nowson CA, Hoang NH, Wark JD. Changes in body composition as determinants of longitudinal changes in bone mineral measures in 8 to 26-year-old female twins. Osteoporos Int 2001 ; 12 : 506-15.
76. Zborowski JV, Cauley JA, Talbott EO, Guzick DS, Winters SJ. Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone [Review]. J Clin Endocrinol Metab 2000 ; 85 : 3496-506.